Prospects of plasmapheresis for patients with severe COVID-19
On February 11, 2020, the World Health Organization officially named the infection caused by the new coronavirus “Coronavirus disease 2019” (COVID-19). On February 11, 2020, the International Committee on Taxonomy of Viruses (ICTV) officially named the infectious matter “severe acute respiratory syn...
Main Authors: | Ilmira R. Gilmutdinova, Maksim Yu. Yakovlev, Petr S. Eremin, Anatoliy D. Fesun |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2020-09-01
|
Series: | European Journal of Translational Myology |
Subjects: | |
Online Access: | https://pagepressjournals.org/index.php/bam/article/view/9165 |
Similar Items
-
COUPLED PLASMAFILTRATION AND ADSORPTION IN SEPTIC COMPLICATIONS IN RENAL TRANSPLANT RECIPIENTS
by: A. V. Vatazin, et al.
Published: (2014-05-01) -
The comparison of the mortality rates of plasmapheresis/hemoperfusion therapy with current treatment among Covid-19 patients
by: Seyede Mahboobeh Raoofi Kelachayeh, et al.
Published: (2022-11-01) -
MODERN CONCEPTS OF SEPSIS PATHOGENESIS AND PERSPECTIVE APPROACH TO IT''S TREATMENT
by: A. B. Zulkarnaev, et al.
Published: (2016-02-01) -
Discrete plasmapheresis for coronary heart disease
by: I N Solov'eva, et al.
Published: (2014-08-01) -
HEMOFILTRATION AND COUPLED PLASMA FILTRATION ADSORPTION IMPACT ON TACROLIMUS BLOOD CONCENTRATION IN RENAL TRANSPLANT RECIPIENTS
by: A.V. Vatazin, et al.
Published: (2014-05-01)